CA
NH

Clearstead Advisors’s NantHealth, Inc NH Stock Holding History

Clearstead Advisors’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-33
Closed -$1K – 1469
2021
Q3 		$1K Hold
33
– – ﹤0.01% 1268
2021
Q2 		$1K Hold
33
– – ﹤0.01% 1232
2021
Q1 		$2K Hold
33
– – ﹤0.01% 995
2020
Q4 		$2K Buy
+33
New +$1.24K ﹤0.01% 910

Other funds holding NH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Clearstead Advisors's NH Position: Q4 2021 in Review

Clearstead Advisors sold out of NantHealth, Inc (NH) in Q4 2021, closing a stake of 33 shares — an estimated $1K sold.

Clearstead Advisors first reported a position in NH in Q4 2020 and held it in 4 quarters. The position peaked at $2K in Q1 2021. 43 funds tracked by Wall St. Rank hold NH as of Q4 2021.

  • Clearstead Advisors reported no remaining NantHealth, Inc position as of Q4 2021 after selling out during the quarter.
  • Clearstead Advisors sold 33 NantHealth, Inc shares in Q4 2021, an estimated $1K.
  • Clearstead Advisors first reported a position in NantHealth, Inc in Q4 2020 and held it in 4 quarters.
  • Clearstead Advisors's NantHealth, Inc position peaked at $2K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2021.

Based on Clearstead Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.